Estimated Control (100%) Announced Transaction verified CPGSupplementsVitaminsVitamins & Supplements

Blackmores acquired by Kirin

Kirin agreed to acquire Blackmores, an Australian vitamins & supplements brand, on Apr 26, 2023.

Transaction summary

Target
Blackmores
Acquirer
Kirin
Seller
-
Announced
2023-04-26
Geography
Australia
Type
Acquisition
Deal type
Control
Stake acquired
100%
First added
2026-06-19
Latest update
2026-07-13

Value and multiples

100% enterprise value

USD 1.2B

100% enterprise value | USD

Basis: Public source

Reported price is assumed to be 100% EV unless stated otherwise. Partial-stake estimates are qualified in the basis notes.

EV / revenue

2.9x

Period not stated

Basis: FundComb estimate

EV / EBITDA

23.1x

EBITDA basis not stated

Basis: Derived from source data

Basis

  • EBITDA derived as enterprise value / EV/EBITDA = A$1,840,000,000 / 23.1 = A$79,653,680. EV source: https://smallcaps.com.au/article/blackmores-kirin-takeover-kogan-profitable-sales-soften-megaport-higher-ebitda. Multiple source: https://www.australianshareholders.com.au/wp-content/uploads/2023/08/BKL_SchemeMeeting_FY23.pdf

Other reviewed estimates

Earlier estimates and their sources.

EBITDA multiple of 24.3x and EV/sales multiple of 2.9x are from the pasted VMS spreadsheet row, not confirmed in supplied public web evidence.
EV / revenue 2.9x | EV / EBITDA 24.3x

Source summary

Japan's Kirin agrees $1.2 billion for Australia's Blackmores in diversification push - Reuters

Confirmed
Open via Google News

Thorne HealthTech Schedule 14D-9/A

Estimated

Precedent transaction row lists implied TEV of $1,241m and TEV/LTM Adjusted EBITDA of 23.1x.

Open source

Blackmores sale to Kirin: Shareholders vote required

Estimated

Shareholder-vote note says the A$95 scheme consideration was fair and reasonable and equated to an acquisition multiple of 23.1x Blackmores EV/EBITDA for the 12 months to Dec. 2022. A separate public article reports the deal implied A$1.88bn equity value and A$1.84bn enterprise value.

Open source

Continue your research

Explore more comps →